Maball 100 mg Injection
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Maball 100 mg Injection

Maball 100 mg Injection

Maball 100 mg Injection contains rituximab 100 mg and is a monoclonal antibody medicine used for certain blood cancers and autoimmune disorders. It is used in conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, and selected autoimmune diseases. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

 

BUY NOW

Category

Rituximab targets the CD20 protein present on B-cells and helps eliminate abnormal B-cells involved in certain cancers and immune disorders. It may be used alone or with chemotherapy and other medicines according to the prescribed treatment protocol. Patients generally require monitoring for infusion-related reactions, infections, blood-count changes, and hepatitis B reactivation during treatment. The dose and infusion schedule depend on the specific condition, treatment regimen, and patient’s clinical response.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Dosage Form Injection
Volume 10 mL
Route of Administration Intravenous infusion
Manufacturer Hetero Healthcare Ltd.

Product Also Known As

Maball 100mg Injection, Maball 100 mg Injection, Maball 100 Injection, Rituximab 100mg Injection, Rituximab 100 mg Injection, Rituximab 100mg Infusion, Rituximab 100mg Vial